Shiba Kahori, Arai Takeo, Sato Shigeto, Kubo Shin-ichiro, Ohba Yusuke, Mizuno Yoshikuni, Hattori Nobutaka
Research Institute for Diseases of Old Age, Juntendo University School of Medicine, Hongo, Bunkyo, Tokyo, Japan.
Biochem Biophys Res Commun. 2009 Jun 5;383(3):331-5. doi: 10.1016/j.bbrc.2009.04.006. Epub 2009 Apr 7.
Parkinson disease (PD) is the most common movement disorder and is characterized by dopaminergic dysfunction. The majority of PD cases are sporadic; however, the discovery of genes linked to rare familial forms of the disease has provided crucial insight into the molecular mechanisms of disease pathogenesis. Multiple genes mediating familial forms of Parkinson's disease (PD) have been identified, such as parkin (PARK2) and phosphatase and tensin homologue deleted on chromosome ten (PTEN)-induced putative kinase 1: PINK1 (PARK6). Here, we showed that Parkin directly interacts with PINK1, but did not bind to pathogenic PINK1 mutants. Parkin, but not its pathogenic mutants, stabilizes PINK1 by interfering with its degradation via the ubiquitin-mediated proteasomal pathway. In addition, the interaction between Parkin and PINK1 resulted in reciprocal reduction of their solubility. Our results indicate that Parkin regulates PINK1 stabilization via direct interaction with PINK1, and operates through a common pathway with PINK1 in the pathogenesis of early-onset PD.
帕金森病(PD)是最常见的运动障碍性疾病,其特征为多巴胺能功能障碍。大多数帕金森病病例为散发性;然而,与该疾病罕见家族形式相关基因的发现为疾病发病机制的分子机制提供了关键见解。已鉴定出多个介导帕金森病(PD)家族形式的基因,如帕金蛋白(PARK2)和第10号染色体缺失的磷酸酶及张力蛋白同源物(PTEN)诱导的假定激酶1:PINK1(PARK6)。在此,我们表明帕金蛋白直接与PINK1相互作用,但不与致病性PINK1突变体结合。帕金蛋白而非其致病性突变体通过干扰其经由泛素介导的蛋白酶体途径的降解来稳定PINK1。此外,帕金蛋白与PINK1之间的相互作用导致它们的溶解度相互降低。我们的结果表明,帕金蛋白通过与PINK1直接相互作用来调节PINK1的稳定性,并在早发性帕金森病的发病机制中与PINK1通过共同途径发挥作用。